NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system (CNS) disorders, ...
The traditional “ monoamine hypothesis ” of depression was proposed more than half a century ago, in the 1950s. This theory ...
Morning Overview on MSN
Single DMT dose delivers long-lasting relief from depression
A single intravenous dose of dimethyltryptamine, the psychoactive compound found in the Amazonian brew ayahuasca, produced significant and lasting reductions in depression symptoms across a ...
No single ‘depression gene’ has been found, but large studies have identified over 100 genetic risk markers on chromosomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results